Movatterモバイル変換

[0]ホーム
URL:

Skip Navigation
CNBC
Markets
  • Pre-Markets
  • U.S. Markets
  • Europe Markets
  • China Markets
  • Asia Markets
  • World Markets
  • Currencies
  • Prediction Markets
  • Cryptocurrency
  • Futures & Commodities
  • Bonds
  • Funds & ETFs
Business
  • Economy
  • Finance
  • Health & Science
  • Media
  • Real Estate
  • Energy
  • Climate
  • Transportation
  • Investigations
  • Industrials
  • Retail
  • Wealth
  • Sports
  • Life
  • Small Business
Investing
  • Personal Finance
  • Fintech
  • Financial Advisors
  • Options Action
  • ETF Street
  • Buffett Archive
  • Earnings
  • Trader Talk
Tech
  • Cybersecurity
  • AI
  • Enterprise
  • Internet
  • Media
  • Mobile
  • Social Media
  • CNBC Disruptor 50
  • Tech Guide
Politics
  • White House
  • Policy
  • Defense
  • Congress
  • Expanding Opportunity
  • Europe Politics
  • China Politics
  • Asia Politics
  • World Politics
Video
  • Latest Video
  • Full Episodes
  • Livestream
  • Top Video
  • Live Audio
  • Europe TV
  • Asia TV
  • CNBC Podcasts
  • CEO Interviews
  • Digital Originals
Watchlist
Investing Club
  • Trust Portfolio
  • Analysis
  • Trade Alerts
  • Meeting Videos
  • Homestretch
  • Jim's Columns
  • Education
  • Subscribe
Join IC
PRO
  • Pro News
  • Josh Brown
  • Mike Santoli
  • Calls of the Day
  • My Portfolio
  • Livestream
  • Full Episodes
  • Stock Screener
  • Market Forecast
  • Options Investing
  • Chart Investing
  • Subscribe
Join Pro
Livestream
  • Make It
  • select
  • USA
  • INTL
  • Livestream
  • Livestream
Watchlist
SIGN IN
Create free account
Markets
Business
Investing
Tech
Politics
Video
Watchlist
Investing Club
Join IC
PRO
Join Pro
Livestream

Business News

Health and Science

  • Coronavirus
  • Biotech and Pharma
  • Health Insurance
  • Hospitals
  • Science
French prosecutors investigate Nestle, Danone over contaminated baby formula. Here's the latest
French prosecutors investigate Nestle, Danone over contaminated baby formula. Here's the latest
Elsa Ohlen2 hours ago
Novo Nordisk faces a defining year in the obesity drug market
Novo Nordisk faces a defining year in the obesity drug market
Annika Kim ConstantinoWed, Feb 11th 2026
How largest health-care education company in U.S. is tackling growing jobs gap
How largest health-care education company in U.S. is tackling growing jobs gap
Ian ThomasWed, Feb 11th 2026
Novo CEO sees 15 million patient opportunity in Medicare obesity coverage
Novo CEO sees 15 million patient opportunity in Medicare obesity coverage
Annika Kim ConstantinoWed, Feb 11th 2026
Moderna says FDA refuses to review its application for experimental flu shot
Moderna says FDA refuses to review its application for experimental flu shot
Annika Kim ConstantinoWed, Feb 11th 2026
CVS tops quarterly estimates, reaffirms profit outlook as turnaround takes hold
Health and Science
CVS tops quarterly estimates, reaffirms profit outlook as turnaround takes hold
Tue, Feb 10th 2026
Florida law models what genetic disease testing could be
CNBC Cures
Florida law models what genetic disease testing could be
Tue, Feb 10th 2026
Health and Science
FDA says Novo Nordisk's TV ad for obesity pill includes misleading claims
Mon, Feb 9th 2026
Health and Science
Novo Nordisk sues Hims & Hers over copycat versions of Wegovy pill, injections
Mon, Feb 9th 2026
Pharmaceuticals
Hims & Hers stops offering weight loss pill after threats of legal action
Mon, Feb 9th 2026

Trending Now

  • 1
    Here’s how much athletes at the 2026 Winter Olympics get for winning medals
  • 2
    Epstein files fallout: The high-profile people burned by past dealings with a predator
  • 3
    Long-term unemployment is becoming 'a status quo' in today's job market: It's a 'mental war,' job seeker says
  • 4
    Highly successful people 'demand more respect' when they use these phrases, says career expert
  • 5
    3 tools used by technical analysts that can give stock pickers a second opinion

More In Health and Science

Healthy Returns: Pfizer execs chart out obesity drug strategy
Healthy Returns
Healthy Returns: Pfizer execs chart out obesity drug strategy
Fri, Feb 6th 2026
White House launches direct-to-consumer drug site TrumpRx. Here's what to know
Health and Science
White House launches direct-to-consumer drug site TrumpRx. Here's what to know
Fri, Feb 6th 2026
Eli Lilly sees GLP-1 growth accelerating as Novo Nordisk braces for a decline
Health and Science
Eli Lilly sees GLP-1 growth accelerating as Novo Nordisk braces for a decline
Wed, Feb 4th 2026
Health and Science
Eli Lilly blows past quarterly estimates, posts strong outlook as GLP-1 sales soar
Wed, Feb 4th 2026
Health and Science
Pfizer says obesity injection shows promise as monthly treatment in mid-stage trial
Tue, Feb 3rd 2026
Health and Science
Pfizer beats quarterly estimates despite Covid product decline, reaffirms outlook
Tue, Feb 3rd 2026
Merck tops quarterly estimates, posts modest outlook as generic competition looms
Health and Science
Merck tops quarterly estimates, posts modest outlook as generic competition looms
Tue, Feb 3rd 2026
Eli Lilly CEO: Medicare coverage of obesity drugs could support pill launch
Health and Science
Eli Lilly CEO: Medicare coverage of obesity drugs could support pill launch
Fri, Jan 30th 2026
Eli Lilly plans $3.5 billion Pennsylvania manufacturing plant for obesity drugs
Health and Science
Eli Lilly plans $3.5 billion Pennsylvania manufacturing plant for obesity drugs
Fri, Jan 30th 2026
Personal Finance
As ACA subsidies expire, health costs emerge as top economic worry for voters: survey
Fri, Jan 30th 2026
CNBC Cures
Breakthrough drug helps 11-year-old battle rare neurological gene mutation
Fri, Jan 30th 2026
Healthy Returns
Healthy Returns: 15 drugs added to Medicare price negotiations
Wed, Jan 28th 2026
Danaher stock fails to rise on solid earnings — leading us to question what's next
Analysis
Danaher stock fails to rise on solid earnings — leading us to question what's next
Wed, Jan 28th 2026
UnitedHealth posts earnings beat, soft revenue guidance as insurer plots turnaround
Health and Science
UnitedHealth posts earnings beat, soft revenue guidance as insurer plots turnaround
Tue, Jan 27th 2026
Next up in weight loss drugs: More pills, easier access and drug combinations
Health and Science
Next up in weight loss drugs: More pills, easier access and drug combinations
Fri, Jan 23rd 2026
Healthy Returns
Healthy Returns: Structure Therapeutics CEO on obesity pills, future of GLP-1s
Wed, Jan 21st 2026
Tech
Amazon launches AI health-care tool for One Medical members
Wed, Jan 21st 2026
Tech
OpenEvidence, the 'ChatGPT for doctors,' doubles valuation to $12 billion
Wed, Jan 21st 2026
Another alliance of health care and AI signals why pharma stocks could be back
Analysis
Another alliance of health care and AI signals why pharma stocks could be back
Tue, Jan 20th 2026
Drug pricing, patent losses, deals: What pharma execs see ahead in the industry
Health and Science
Drug pricing, patent losses, deals: What pharma execs see ahead in the industry
Tue, Jan 20th 2026
Novo Nordisk shares rise after Wegovy obesity pill has 'solid' start to launch
Health and Science
Novo Nordisk shares rise after Wegovy obesity pill has 'solid' start to launch
Fri, Jan 16th 2026
CNBC Cures
Keeping U.S. biotech ahead of China's could help rare disease patients, experts say
Tue, Jan 20th 2026
Healthy Returns
Healthy Returns: Novo CEO on GLP-1 pricing, and more insights from the JPM conference
Fri, Jan 16th 2026
Tech
OpenAI acquires health-care technology startup Torch for $60 million: Source
Mon, Jan 12th 2026
CNBC logo
  • Subscribe to CNBC PRO
  • Subscribe to Investing Club
  • Licensing & Reprints
  • CNBC Councils
  • Join the CNBC Panel
  • Digital Products
  • News Releases
  • Closed Captioning
  • Corrections
  • About CNBC
  • Internships
  • Site Map
  • Careers
  • Help
  • Contact

  • News Tips

    Got a confidential news tip? We want to hear from you.

    Get In Touch

  • CNBC Newsletters

    Sign up for free newsletters and get more CNBC delivered to your inbox

    Sign Up Now

    Get this delivered to your inbox, and more info about our products and services.

  • Advertise With Us

    Please Contact Us
  • Ad Choices
  • Privacy Policy
  • California Consumer Privacy Act (CCPA) Opt-Out IconYour Privacy Choices
  • CA Notice
  • Terms of Service

© 2026 Versant Media, LLC. All Rights Reserved. A Versant Media Company.

Data is a real-time snapshot *Data is delayed at least 15 minutes. Global Business and Financial News, Stock Quotes, and Market Data and Analysis.

Market Data Terms of Use and Disclaimers

Data also provided byReuters logo

[8]ページ先頭
©2009-2026 Movatter.jp